SBSN and myelodysplastic syndrome: Intriguingly, SBSN mRNA level in the MDS BM patients' samples (n = 30) was significantly higher compared to either the HM group (n = 19; P = 0.0053; Fig. 1C) or healthy donors (n = 8) in which the level of SBSN mRNA was low or undetectable.